Pharma Investments, Ventures & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
BioMed Realty Trust, Inc.
BioMed Realty Trust Announces Exercise of Over-Allotment Option
October 26th, 2008
BioMed Realty Trust, Inc. (NYSE:BMR) announced that on October 1, 2008 the underwriter exercised its over-allotment option in full to purchase an additional 1,125,000 shares of common stock in connection with BioMed's previously announced offering that priced on October 1, 2008. In total, the company sold 8,625,000 shares of common stock, raising net proceeds of approximately $212.4 million after deducting underwriter discounts and commissions and estimated expenses. UBS Investment Bank is acting as the sole underwriter for the offering. The registration statement relating to these securities has become effective by rule of the Securities and Exchange Commission. This...
Source: Pharma Investments, Ventures & Law Weekly (2008-10-26)
|
